170 related articles for article (PubMed ID: 10095980)
41. Twenty-four month comparison of apolipoproteins A-1, A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom.
Mascarenhas L; van Beek A; Bennink HC; Newton J
Contraception; 1998 Oct; 58(4):215-9. PubMed ID: 9866002
[TBL] [Abstract][Full Text] [Related]
42. Implant contraception.
Meckstroth KR; Darney PD
Semin Reprod Med; 2001 Dec; 19(4):339-54. PubMed ID: 11727176
[TBL] [Abstract][Full Text] [Related]
43. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
[TBL] [Abstract][Full Text] [Related]
44. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
[TBL] [Abstract][Full Text] [Related]
45. The impalpable Implanon: a case report.
Stillwell S; Sheppard P; Searle S
J Fam Plann Reprod Health Care; 2003 Jul; 29(3):156-7. PubMed ID: 12885313
[TBL] [Abstract][Full Text] [Related]
46. Implanon contraceptive implants: effects on carbohydrate metabolism.
Biswas A; Viegas OA; Coeling Bennink HJ; Korver T; Ratnam SS
Contraception; 2001 Mar; 63(3):137-41. PubMed ID: 11368985
[TBL] [Abstract][Full Text] [Related]
47. The significance of bleeding patterns in Norplant implant users.
Shoupe D; Mishell DR; Bopp BL; Fielding M
Obstet Gynecol; 1991 Feb; 77(2):256-60. PubMed ID: 1899135
[TBL] [Abstract][Full Text] [Related]
48. Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route.
Coutinho EM; O'Dwyer E; Barbosa IC; Gu ZP; Shaaban MM; Aboul-Oyoon M; Abdel Aleem H
Contraception; 1995 Jun; 51(6):355-8. PubMed ID: 7554976
[TBL] [Abstract][Full Text] [Related]
49. Bleeding patterns for the Liletta
Schreiber CA; Teal SB; Blumenthal PD; Keder LM; Olariu AI; Creinin MD
Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):116-120. PubMed ID: 29560743
[TBL] [Abstract][Full Text] [Related]
50. Endometrial angiogenic response in Norplant users.
Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
[TBL] [Abstract][Full Text] [Related]
51. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
[TBL] [Abstract][Full Text] [Related]
52. A longitudinal study of changes in endometrial microvascular density in Norplant implant users.
Hickey M; Simbar M; Young L; Markham R; Russell P; Fraser IS
Contraception; 1999 Feb; 59(2):123-9. PubMed ID: 10361627
[TBL] [Abstract][Full Text] [Related]
53. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
[TBL] [Abstract][Full Text] [Related]
54. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill.
Eur J Contracept Reprod Health Care; 1998 Dec; 3(4):169-78. PubMed ID: 10036599
[TBL] [Abstract][Full Text] [Related]
55. Spontaneous snapping of an Implanon in two halves in situ.
Agrawal A; Robinson C
J Fam Plann Reprod Health Care; 2003 Oct; 29(4):238. PubMed ID: 14662060
[TBL] [Abstract][Full Text] [Related]
56. [Vaginal bleeding patterns and the regularity in use of Norplant].
Meng F; Fan H; Han L
Zhonghua Yi Xue Za Zhi; 1996 May; 76(5):331-4. PubMed ID: 9206192
[TBL] [Abstract][Full Text] [Related]
57. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
Sivin I
Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
[TBL] [Abstract][Full Text] [Related]
58. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
Darney PD; Taylor RN; Klaisle C; Bottles K; Zaloudek C
Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
[TBL] [Abstract][Full Text] [Related]
59. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
Lau TM; Witjaksono J; Affandi B; Rogers PA
Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
[TBL] [Abstract][Full Text] [Related]
60. Economic analysis of long-term reversible contraceptives. Focus on Implanon.
Phillips CJ
Pharmacoeconomics; 2000 Feb; 17(2):209-21. PubMed ID: 10947343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
